Phase 1 Single Ascending Dose Study With ATX101

Clinical trial NCT07107802 · COMPLETED

Trial details

NCT number: NCT07107802
Sponsor: Aurobac Therapeutics SAS
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2025-07-19
Primary completion: 2025-10-24
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.